Home › Funds › KVP Capital Advisors, LP › STRO

KVP Capital Advisors, LP position in STRO

SUTRO BIOPHARMA INC · Health Care

KVP Capital Advisors, LP reported holding 226,575 shares of STRO (SUTRO BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$7.5M, representing 5.52% of its reported portfolio and ranking #5 among its reported holdings. KVP Capital Advisors, LP has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)226.57K sh
Reported value held$7.52M
Portfolio Weight5.52%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's STRO position evolved

KVP Capital Advisors, LP first disclosed a stake in STRO in Q1 2026 at 226,575 shares (US$5.6M). The position peaked in Q2 2026 at 226,575 shares, worth US$7.5M. Across 2 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 226,575 shares valued at US$7.5M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 226.57K $5.64M New
Q2 2026 226.57K $7.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STRO and 13F data

STRO (SUTRO BIOPHARMA INC) is a Health Care company. 45 other funds we track also report a position in STRO — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$43.3M), BVF INC/IL (US$41.6M), Affinity Asset Advisors, LLC (US$38.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STRO

All STRO fund holders →

FAQ

How long has KVP Capital Advisors, LP held STRO?

KVP Capital Advisors, LP has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is KVP Capital Advisors, LP's current position in STRO?

As of Q2 2026, KVP Capital Advisors, LP holds 226.57K shares of STRO (SUTRO BIOPHARMA INC), valued at $7.52M, representing 5.52% of its reported portfolio and ranking #5.

Has KVP Capital Advisors, LP been buying or selling STRO?

In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP held unchanged its position in STRO. The position peaked in Q2 2026 at 226.57K shares.

Which other funds hold STRO?

Other major institutional holders of STRO include PERCEPTIVE ADVISORS LLC, BVF INC/IL, Affinity Asset Advisors, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.